白云山：已完成大部分品牌授权整顿清理工作

证券之星07-23 18:09

证券之星消息，白云山(600332)07月23日在投资者关系平台上答复投资者关心的问题。

投资者提问：请问董秘，公司清理贴牌的进展如何？其中是否包括健码制药的白云山肺槲皮素紫苏籽槐米玉竹百合石斛复合片，是什么批号？

白云山回复：尊敬的投资者您好，感谢您的关注！公司已强化相关制度及加强品牌管理，持续清理整顿存量贴牌授权产品，截止目前已完成大部分品牌授权整顿清理工作。目前该产品是公司属下企业自营产品。

本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。

责任编辑：刘浩然

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2653674621?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-23 18:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653674621","market":"hk","top_or_hot":-1,"title":"白云山：已完成大部分品牌授权整顿清理工作","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/600332\">白云山</a>(600332)07月23日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：请问董秘，公司清理贴牌的进展如何？其中是否包括健码制药的<a href=\"https://laohu8.com/S/00874\">白云山</a>肺槲皮素紫苏籽槐米玉竹<a href=\"https://laohu8.com/S/603102\">百合</a>石斛复合片，是什么批号？</p><p>白云山回复：尊敬的投资者您好，感谢您的关注！公司已强化相关制度及加强品牌管理，持续清理整顿存量贴牌授权产品，截止目前已完成大部分品牌授权整顿清理工作。目前该产品是公司属下企业自营产品。</p><p>本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。</p><p>责任编辑：刘浩然</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>白云山：已完成大部分品牌授权整顿清理工作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n白云山：已完成大部分品牌授权整顿清理工作\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-23 18:09 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026072300037515.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，白云山(600332)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，公司清理贴牌的进展如何？其中是否包括健码制药的白云山肺槲皮素紫苏籽槐米玉竹百合石斛复合片，是什么批号？白云山回复：尊敬的投资者您好，感谢您的关注！公司已强化相关制度及加强品牌管理，持续清理整顿存量贴牌授权产品，截止目前已完成大部分品牌授权整顿清理工作。目前该产品是公司属下企业自营产品。本文...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026072300037515.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0012","symbol_name":"证金概念","start_time":0,"source_url":"https://stock.stockstar.com/RB2026072300037515.shtml","article_id":"2653674621","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653674621","pubTimestamp":1784801348,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，白云山(600332)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，公司清理贴牌的进展如何？其中是否包括健码制药的白云山肺槲皮素紫苏籽槐米玉竹百合石斛复合片，是什么批号？白云山回复：尊敬的投资者您好，感谢您的关注！公司已强化相关制度及加强品牌管理，持续清理整顿存量贴牌授权产品，截止目前已完成大部分品牌授权整顿清理工作。目前该产品是公司属下企业自营产品。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600332":"白云山","BK0012":"证金概念","BK0183":"MSCI概念","BK0175":"白马股","BK0196":"行业龙头","BK1521":"挪威政府全球养老基金持仓","BK1606":"中医药概念","BK0097":"医药电商","BK0239":"医药制造","BK0028":"国家队","00874":"白云山","BK1197":"保健护理产品经销商","BK1515":"抗疫概念","BK1191":"制药","BK0096":"民营医院","BK0188":"融资融券","BK0070":"员工持股"},"translate_title":"Baiyunshan: Most brand authorization rectification and cleaning work has been completed","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":1.5,"00874":1.5},"content_text":"证券之星消息，白云山(600332)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，公司清理贴牌的进展如何？其中是否包括健码制药的白云山肺槲皮素紫苏籽槐米玉竹百合石斛复合片，是什么批号？白云山回复：尊敬的投资者您好，感谢您的关注！公司已强化相关制度及加强品牌管理，持续清理整顿存量贴牌授权产品，截止目前已完成大部分品牌授权整顿清理工作。目前该产品是公司属下企业自营产品。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653674621","isCrawlerRequest":true}